Autopsy report · NCT01116440
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 11 months before it stopped.
- 27 participants enrolled.
- Results were posted on the registry 8 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Mereo BioPharma
- Sponsor type
- Industry
- Conditions
- Pelvic Pain Associated With Refractory Endometriosis
- Interventions
- BGS649; Placebo
- Participants
- 27
- Sites
- 44
- Countries
- Puerto Rico, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.